| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
|
Linge, Jennifer
|
|
|
5 |
3 |
p.
|
artikel
|
| 2 |
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
|
Burm, Rani
|
|
|
5 |
3 |
p.
|
artikel
|
| 3 |
Contents
|
|
|
|
5 |
3 |
p.
|
artikel
|
| 4 |
Copyright and information
|
|
|
|
5 |
3 |
p.
|
artikel
|
| 5 |
CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma
|
Romero-Cristóbal, Mario
|
|
|
5 |
3 |
p.
|
artikel
|
| 6 |
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer
|
Christensen, Troels D.
|
|
|
5 |
3 |
p.
|
artikel
|
| 7 |
Editorial Board page
|
|
|
|
5 |
3 |
p.
|
artikel
|
| 8 |
Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes
|
Duponchel, Sarah
|
|
|
5 |
3 |
p.
|
artikel
|
| 9 |
Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries
|
Tseligka, Eirini D.
|
|
|
5 |
3 |
p.
|
artikel
|
| 10 |
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis
|
Villeret, François
|
|
|
5 |
3 |
p.
|
artikel
|
| 11 |
Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)
|
Marcellin, Fabienne
|
|
|
5 |
3 |
p.
|
artikel
|
| 12 |
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
|
Maasoumy, Benjamin
|
|
|
5 |
3 |
p.
|
artikel
|
| 13 |
Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status
|
Lee, Mei-Hsuan
|
|
|
5 |
3 |
p.
|
artikel
|
Tijdschrift beschrijving